News
Press Releases
February 20, 2025 06:15 pm
Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement
February 20, 2025 07:30 am
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
February 19, 2025 01:10 pm
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
September 3, 2024 08:01 am
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements
September 3, 2024 07:25 am
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA-Approved Drugs, Nutraceuticals and Supplements
July 31, 2024 08:01 am
Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.
July 31, 2024 07:28 am
Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.
June 5, 2024 04:05 pm